CClinicalTrials.gg
CompletedNCT00698529Updated Jul 11, 2019

Effectiveness of Communication Technology in Disseminating HIV Prevention Training to Non-governmental Organizations

A Phase 2 interventional study of Face-to-face training and Distance training in HIV Infections, sponsored by Medical College of Wisconsin. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-07-11.

Sponsored by Medical College of Wisconsin · Phase 2, Interventional, and Prevention

Phase
Phase 2
Study type
Interventional
Enrollment
99
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study will compare the effectiveness of face-to-face training versus Web-based training seminars in disseminating HIV prevention interventions to nongovernmental organizations in Eastern Europe and Central Asia.

Read the detailed description

An estimated total of 60 million people have been infected with HIV since the first cases were reported in the early 1980s. Although the HIV/AIDS pandemic is a global crisis, certain regions have been affected more than others. The Eastern European and Central Asian region, in particular, has one of the fastest growing rates of HIV infections in the world. Most new HIV infections in this region have been occurring among injection drug users, commercial sex workers, and men who have sex with men, but the virus continues to increasingly affect the general population, too. HIV prevention interventions that are able to be disseminated to a large population are necessary. The Popular Opinion Leader (POL) intervention is an HIV prevention program that recruits and trains opinion leaders in the community to promote safe sex behaviors through risk-reduction conversations with peers. Administering the POL intervention to nongovernmental organizations (NGOs) may be an effective means of assuring that the intervention is extended throughout the region. However, the best means of disseminating the POL program and assuring its full adoption by NGOs is unknown. This study will compare the effectiveness of face-to-face training versus Web-based training seminars in disseminating the POL intervention to NGOs in Eastern Europe and Central Asia.

Participation in this study will last 24 months. Potential NGOs will first undergo baseline assessments that will include an in-depth 90-minute phone interview with the NGO director and completion of attitude scales about the POL HIV intervention. NGOs will then be assigned randomly to one of three study groups:

  • Participating NGOs in Group 1 will receive the POL intervention through face-to-face training. Staff will receive 2-day training on the POL intervention and individualized telephone follow-up consultations concerning POL implementation.
  • Participating NGOs in Group 2 will receive the POL intervention through Web-based training. Staff will receive training delivered entirely by means of a Web-based, distance learning curriculum. Staff will also be offered individualized telephone follow-up consultations concerning POL implementation.
  • Participating NGOs in Group 3 will receive no intervention.

All participating NGOs will undergo follow-up assessments 12 and 24 months after completing the intervention training. Assessments will include a 90-minute phone interview with the NGO director and a 10-minute phone interview with NGO staff members to assess attitudes concerning the intervention, their adoption of the core elements of the intervention model, and the extent of usage of training materials. A number of NGOs that report full adoption of the POL intervention will be selected randomly to undergo a 2-day validation site visit by an assessment team member. Site visits will be used to conduct interviews with NGO staff and the opinion leaders, validate reports of intervention adoption, observe POL sessions, and review materials used in training sessions.

02

Conditions studied

  • HIV Infections

Browse trials for

Keywords

  • Technology Transfer
  • HIV Seronegativity
03

In context

HIV Infections

4,258 studies on the registry are indexed under HIV Infections; 240 are open to participants now.

This study's enrollment of 99 is above the median of 83 across 3,251 interventional studies indexed under HIV Infections.

Browse HIV Infections studies →

Lead sponsor

Medical College of Wisconsin is the lead sponsor of 540 studies on the registry; 119 are open to participants now.

Of its 71 completed or terminated interventional studies of FDA-regulated products, 56 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Located in Eastern Europe or Central Asia
  • Currently offers direct HIV prevention interventions targeting sexual risk in a community population
  • Director willing to provide organizational consent
  • Director and staff members willing to provide individual consent
  • Director and staff members fluent in either English or Russian
  • Has reliable Internet access

Exclusion criteria

Exclusion Criteria for NGOs:

  • Participated in prior Medical College of Wisconsin dissemination study
05

Study design

Phase
Phase 2
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
99 participants (actual)

Study arms

  • No intervention
    No POL Training

    Participating NGOs and their staff will receive no specialized training.

  • Experimental
    Face-to-Face

    Participating NGOs and their staff will receive training through face-to-face seminars held at the NGOs and through post-seminar consultation telephone calls.

    Behavioral: Face-to-face training · Behavioral: Popular Opinion Leader (POL)

  • Experimental
    Distance Learning

    Participating NGOs and their staff will receive training through Web-based seminars and through post-seminar consultation telephone calls.

    Behavioral: Distance training · Behavioral: Popular Opinion Leader (POL)

Interventions

  • BehavioralFace-to-face training

    NGOs will receive the POL intervention through face-to-face training. Staff will receive 2-day training on the POL intervention and individualized telephone follow-up consultations concerning POL implementation.

    Also known as: Traditional, Seminar

  • BehavioralDistance training

    NGOs will receive the POL intervention through Web-based training. Staff will receive training delivered entirely by means of a Web-based, distance learning curriculum and through individualized telephone follow-up consultations concerning POL implementation.

    Also known as: On-line, Internet, Distance learning

  • BehavioralPopular Opinion Leader (POL)

    POL is a community-level HIV intervention that recruits and trains opinion leaders in the community to promote safe sex behaviors through risk-reduction conversations with peers.

06

What researchers measure

Primary outcomes

  1. Adoption of the full Popular Opinion Leader intervention by a nongovernmental organization (NGO)

    Time frame: Measured at Months 12 and 24 after training

Secondary outcomes

  1. Number of core elements of the Popular Opinion Leader intervention incorporated into NGO HIV prevention interventions

    Time frame: Measured at Months 12 and 24 after training

  2. Cost effectiveness of training method

    Time frame: Measured at Month 24 after training

07

Study locations

1 site
  • Center for AIDS Intervention Research, Medical College of Wisconsin
    Milwaukee, Wisconsin 53226, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 11, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00698529
Lead sponsor
Medical College of Wisconsin
Collaborators
National Institute of Mental Health (NIMH)
Responsible party
Jeffrey Kelly (Professor of Psychiatry and Behavioral Medicine, Medical College of Wisconsin) — Principal investigator
First posted
Jun 17, 2008
Start date
Nov 2008
Primary completion
Feb 2013
Completion
Jul 1, 2019
Last update
Jul 11, 2019

Study contacts

Jeffrey A. Kelly, PhD
principal investigator · Medical College of Wisconsin
Yuri A. Amirkhanian, PhD
study director · Medical College of Wisconsin
Timothy L. McAuliffe, PhD
study director · Medical College of Wisconsin
Laura R. Glasman, PhD
study director · Medical College of Wisconsin
Steven D. Pinkerton, PhD
study director · Medical College of Wisconsin

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion